ChIP Sequencing Q&A

  • General Questions

  • How do I design a ChIP-Seq experiment?
    • (1) Consider the use of specific antibodies to effectively enrich DNA fragments depending on the study objectives.
      (2) For different cell types, specific nuclei extraction methods need to be used to obtain intact and sufficient nuclei.
      The main difficulty with ChIP-seq is the availability of the antibodies used for immunoprecipitation and the ability to extract sufficient amounts of intact nuclei.
  • Should I choose ChIP-Seq or ChIP-chip?
    • (1) ChIP-Seq enables true genome-wide analysis. The currently available probes fixed on the chip only represent partial sequences of the whole genome, and the hybridization information obtained is biased.
      (2) For binding site analysis, ChIP-Seq can achieve a binding resolution of 10-30 bp by searching for "peaks", while the probes on the chip cannot be precisely located due to their length, and even the highest level of commercial chips currently available cannot provide a resolution comparable to that of ChIP-Seq.
      (3) The number of samples is required. ChIP-chip requires up to 4-5 μg sample, which requires LM-PCR before hybridization, but may result in false positives due to increased background, competitive amplification, etc. ChIP-Seq, on the other hand, requires only nanograms of starting material, which can be as low as 20 ng.
  • What ChIP-Seq library construction method do you use?
    • Illumina sequencing is used to construct its ChIP-seq sequencing libraries as follows:
      (1) ChIP enrichment of DNA fragments.
      (2) Construction of sequencing libraries. After purification of the ChIP-enriched DNA fragments, a series of treatments such as end-flattening, 3' end addition and ligated junction were performed, and the fragments in the range of 150-300 bp were recovered by electrophoretic gel cutting, and then the recovered DNA fragments were amplified by PCR and sequenced on the machine. The sequences measured are first subjected to genomic alignment and then to binding site enumeration using different algorithms.
  • What are the main steps in a ChIP-seq experiment?
    • (1) Histone cross-linking and extraction of nuclei
      (2) Nuclear membrane rupture and genome fragmentation
      (3) Pre-clearing and immunoprecipitation
      (4) Uncrosslinking and DNA purification
      (5) End Repair and Linkage
      (6) Purification and fragment sorting
      (7) Library amplification and quality control
  • Is PCR amplification required during the sample preparation process and does it affect the final result after PCR amplification?
    • Since the amount of DNA samples from ChIP is very small, a PCR amplification step is required during the sample preparation process. The main purpose of PCR amplification is to obtain sufficient amount of DNA for on-line reaction. If the customer can provide sufficient amount of DNA samples, we do not perform PCR amplification anymore. Since it is a linear amplification, the results before and after amplification are very similar and basically do not affect the sequencing results.
  • What other factors can affect the results of ChIP-Seq?
    • Antibody quality, specificity, experimental design, experimental operation of ChIP, DNA fragment length range, sequencing throughput, sequencing quality, etc. all affect the results of ChIP-Seq.
  • How to select antibodies for Chip-Seq?
    • (1) In terms of antibody quality requirements, antibodies for ChIP experiments should be of ChIP/IP grade or higher.
      (2) If you want to study the binding site of a specific transcription factor in the whole genome, you need to use a specific antibody generated with that transcription factor as the antigen. If the antibody is difficult to obtain or not effective, you can also try to use a labeled antibody, which is better when the subject is a plant.
      (3) Labeled antibodies such as His, GFP, Flag, HA, etc. can be chosen. However, there are some risks associated with the tag system. First, whether the fusion of the tag protein will affect the ability of the transcription factor to bind DNA. Second, whether the tag protein itself has the ability to bind DNA, which can produce false positive results. Last, whether the tag fusion protein will compete with the original transcription factor to bind DNA and weaken ChIP enrichment.
  • How to set up the Input control for ChIP sequencing?
    • Before immunoprecipitation, you need to take a part of the broken chromatin for Input control. Input control is the broken genomic DNA, which needs to go through reverse cross-linking, DNA purification, and final PCR or other methods to detect together with the precipitated sample DNA. Input control not only can verify the effect of chromatin breakage, but also can be used to calculate the efficiency of ChIP.
  • How to set up positive control and negative control for ChIP sequencing?
    • Positive and negative controls are the most basic experimental controls. Positive controls usually choose antibodies to more conserved proteins that bind to known sequences, commonly used include histone antibodies or RNA Polymerase II antibodies, etc. Negative controls are usually selected from IgG or serum of the target protein antibody host. The results of the target protein antibody are compared with positive and negative controls in order to draw the correct conclusions.
      If the target protein does not have a commercial antibody suitable for chromatin immunoprecipitation assays and only antibodies for other purposes are available, a protein immunoprecipitation test can be done first. If the antibody can successfully precipitate the protein, then the chromatin immunoprecipitation assay will be performed.
  • What are the factors that lead to false positives for ChIP-Seq?
    • High-throughput sequencing does greatly improve the resolution of ChIP assays, but it is not the only determinant of high resolution. The length of interrupted chromatin fragments after immune-enrichment also affects the resolution. DNA fragmentation methods, chromatin accessibility, PCR amplification bias, genome duplication, and errors in sequencing and sequence alignment can all introduce systematic errors that cause false positives.
  • What data processing methods can be used to estimate the reliability of ChIP-seq raw data?
    • After sequencing, sequences are first matched to known genomes and the true binding sites (peaks) are established. For transcription factors, the downstream regulatory genes (target genes) corresponding to the "peaks" are searched for, or conserved binding sequences for the binding sites of the transcription factors are constructed, and if the motifs of the transcription factors are known, the percentage of the "peaks" containing the motif sequences can be calculated. If the motif of the transcription factor is known, the percentage of motif sequences in the "peak" sequence can be calculated, which can indirectly estimate the reliability of the experimental results.
  • Do I need to perform qPCR assays after ChIP?
    • A qPCR assay is usually performed after the completion of ChIP. If you are studying histone modifications, then a gene that is modified by the histone but not affected by the histone modification is required as a control for qPCR. A high enrichment ploidy (treatment/input) of the gene will indicate a significant enrichment of ChIP. If the study is on transcription factors, several pairs of primers can be designed for potential target genes against their gene regions and promoter regions to test the specificity of ChIP enrichment.
  • What is the difference between agarose beads and magnetic beads during immunoprecipitation, and which Beads are more effective?
    • Agarose beads have non-specific binding and therefore need to be pre-washed with chromatin to remove proteins or DNA that may be non-specifically bound to protein G agarose, and the stratification is not obvious and samples are easily lost. The advantage of magnetic beads is that the sample does not need to be centrifuged, the operation time is short, and the surface of the beads is smooth and the background is low, thus eliminating the need for containment. Another advantage of magnetic beads is that they are color-coded and have a clear stratification so that the sample is not lost, but they require a magnetic holder.

  • Sample Preparation

  • What are the sample requirements for ChIP-Seq?
    • (1) DNA samples: concentration ≥ 10 ng/ul, total amount ≥ 20 ng, OD260/280 = 1.8-2.2. If the amount of DNA is not enough after a single ChIP, it is recommended to combine the DNA from 2-3 ChIPs together.
      (2) The main band of DNA electrophoresis after interruption is required to be within the range of 100-500 bp. Primers can be designed for QPCR verification and quantification of DNA obtained by ChIP.
  • How to extract cell nuclei for ChIP-Seq?
    • To prevent the nuclear membrane from rupture, a large number of genomic fragments can be lost. To extract nuclei, we need to pay attention to the following aspects: firstly, we need to build a suitable buffer system to maintain the osmotic pressure balance of the nuclear membrane; secondly, we need to control the rotational speed during centrifugation to prevent the nuclear membrane from rupture; thirdly, we need to label the nuclei with fluorescent dyes to detect the integrity of the nuclei after extraction.
  • What are the animal cell sample requirements for ChIP-Seq?
    • The number of animal cells used for ChIP should preferably be 107 or more, otherwise, it is difficult to enrich enough DNA fragments for library construction. To obtain nuclei with fewer impurities or to separate cells in different states, density gradient centrifugation is required. If the nuclei need to be stored after extraction, they need to be snap-frozen in liquid nitrogen and stored at -80°C.
  • Do I need to electrophoresis the DNA samples for ChIP-Seq experiments?
    • Electrophoresis is necessary to (1) test the effect of ultrasonic fragmentation, ChIP fragmentation requires between 100bp-900bp, too short to ensure the integrity of the histone/transcription factor binding region lost part of the information, too long to contain non-target region false positive; (2) test the integrity of genomic DNA, for ultrasonic fragmentation of the sample DNA should be a single band of intact genomic DNA.
  • What are the considerations for ultrasonic fragmentation for ChIP experiments?
    • (1) When using a probe-based ultrasonic fragmentation instrument, select a probe that is appropriate for your sample volume.
      (2) In any case, shear parameters should be optimized for your sample volume, cell density, and cell type.
      (3) Optimization should include power settings (sonication time vs. interval time/rest time) and the number of shearing cycles required to obtain DNA fragments of length 200-1000 bp, optimizing only one parameter per optimization experiment.
      (4) Pay attention to the time and power settings. Excessive fragmentation and too high power settings can damage epitopes in the immunoprecipitation step.
      (5) Always keep the lysate ice cold and sonicate intermittently rather than continuously, as heat generated by sonication can denature chromatin.
      (6) Avoid air bubbles during sonication fragmentation. Bubbles cause surface denaturation of the protein and may cause chromatin loss in the bubbles. To avoid this, set the power to a lower level at first and then gradually increase it.
For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.
Related Services
ChIP-Seq
ChIP-Seq
PDF Download
* Email Address:

CD Genomics needs the contact information you provide to us in order to contact you about our products and services and other content that may be of interest to you. By clicking below, you consent to the storage and processing of the personal information submitted above by CD Genomcis to provide the content you have requested.

×
Request a Demo Report

Interested in seeing a sample project report? Complete the form below and our team will send the requested demo report to your email.

* Email Address:
* Demo Report of Interest:
Name:
* Organization:
Other Questions or Requests:
For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.
×
Quote Request
! For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.